Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kiyoshi Maeda

Showing results (371-380 of 391) with videos related to

Pageof 40
Sort By:
Oncology Reports|October 9, 2013
New molecular staging with G-factors (VEGF-C and Reg IV) by supplementing TNM classification in colorectal cancersTetsuji Sawada, Masakazu Yashiro, Kazuhiro Sentani, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 13, 2011
[Docetaxel with concurrent radiotherapy in patients with inoperable or relapsed oesophageal cancer]Naoshi Kubo, Jyunya Morimoto, Katsunobu Sakurai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
[Successful treatment of locally advanced squamous cell carcinoma of the esophagus by combination chemotherapy with 5-fluorouracil plus nedaplatin following tracheal stent tube placement-a case report]Junya Nishimura, Naoshi Kubo, Tomohiro Lee, et al.
BMC Surgery|July 14, 2017
A case of bowel perforation due to traumatic hernia at a pelvic fracture site: a case report and review of the literatureRyota Tanaka, Hisashi Nagahara, Kiyoshi Maeda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 13, 2011
[A case of type 4 gastric cancer with positive peritoneal lavage cytology, which relapsed at the peritoneum at the time of seven years and eight months after resection]Masanori Nakamura, Naoshi Kubo, Junya Morimoto, et al.
Surgery Today|December 17, 2013
Risk factors for surgical site infection in Japanese patients with ulcerative colitis: a multicenter prospective studyToshimitsu Araki, Yoshiki Okita, Motoi Uchino, et al.
BMC Cancer|February 16, 2022
Prospective observational study of the efficacy of oral uracil and tegafur plus leucovorin for stage II colon cancer with risk factors for recurrence using propensity score matching (JFMC46-1201)Sotaro Sadahiro, Kazuhiro Sakamoto, Takashi Tsuchiya, et al.
Cancer Medicine|April 25, 2026
Simultaneous Establishment of Autologous Colorectal Cancer and Mesothelial Stromal Cell Lines from Malignant Ascites Reveals a Mesothelial-Stromal FGFR3 Axis as a Potential Vulnerability in Peritoneal MetastasisYasuhiro Fukui, Hiroaki Kasashima, Zizhou Wang, et al.
Clinical Colorectal Cancer|June 13, 2015
Treatment Rationale and Study Design for Clinical Trial on the Efficacy of UFT/LV for Stage II Colorectal Cancer With Risk Factors for Recurrence (JFMC46-1201)Sotaro Sadahiro, Satoshi Morita, Kazuaki Sasaki, et al.
International Journal of Clinical Oncology|June 4, 2024
Final analyses of the prospective controlled trial on the efficacy of uracil and tegafur/leucovorin as an adjuvant treatment for stage II colon cancer with risk factors for recurrence using propensity score-based methods (JFMC46-1201)Yutaka Ogata, Sotaro Sadahiro, Kazuhiro Sakamoto, et al.
Pageof 40

Showing results (371-380 of 391) with videos related to

Sort By:
Pageof 40
Oncology Reports|October 9, 2013
New molecular staging with G-factors (VEGF-C and Reg IV) by supplementing TNM classification in colorectal cancersTetsuji Sawada, Masakazu Yashiro, Kazuhiro Sentani, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 13, 2011
[Docetaxel with concurrent radiotherapy in patients with inoperable or relapsed oesophageal cancer]Naoshi Kubo, Jyunya Morimoto, Katsunobu Sakurai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
[Successful treatment of locally advanced squamous cell carcinoma of the esophagus by combination chemotherapy with 5-fluorouracil plus nedaplatin following tracheal stent tube placement-a case report]Junya Nishimura, Naoshi Kubo, Tomohiro Lee, et al.
BMC Surgery|July 14, 2017
A case of bowel perforation due to traumatic hernia at a pelvic fracture site: a case report and review of the literatureRyota Tanaka, Hisashi Nagahara, Kiyoshi Maeda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 13, 2011
[A case of type 4 gastric cancer with positive peritoneal lavage cytology, which relapsed at the peritoneum at the time of seven years and eight months after resection]Masanori Nakamura, Naoshi Kubo, Junya Morimoto, et al.
Surgery Today|December 17, 2013
Risk factors for surgical site infection in Japanese patients with ulcerative colitis: a multicenter prospective studyToshimitsu Araki, Yoshiki Okita, Motoi Uchino, et al.
BMC Cancer|February 16, 2022
Prospective observational study of the efficacy of oral uracil and tegafur plus leucovorin for stage II colon cancer with risk factors for recurrence using propensity score matching (JFMC46-1201)Sotaro Sadahiro, Kazuhiro Sakamoto, Takashi Tsuchiya, et al.
Cancer Medicine|April 25, 2026
Simultaneous Establishment of Autologous Colorectal Cancer and Mesothelial Stromal Cell Lines from Malignant Ascites Reveals a Mesothelial-Stromal FGFR3 Axis as a Potential Vulnerability in Peritoneal MetastasisYasuhiro Fukui, Hiroaki Kasashima, Zizhou Wang, et al.
Clinical Colorectal Cancer|June 13, 2015
Treatment Rationale and Study Design for Clinical Trial on the Efficacy of UFT/LV for Stage II Colorectal Cancer With Risk Factors for Recurrence (JFMC46-1201)Sotaro Sadahiro, Satoshi Morita, Kazuaki Sasaki, et al.
International Journal of Clinical Oncology|June 4, 2024
Final analyses of the prospective controlled trial on the efficacy of uracil and tegafur/leucovorin as an adjuvant treatment for stage II colon cancer with risk factors for recurrence using propensity score-based methods (JFMC46-1201)Yutaka Ogata, Sotaro Sadahiro, Kazuhiro Sakamoto, et al.
Pageof 40